Biopsafe ApS: Financial statements 2019
CVR: 33575505
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 6,339,646 and a net result of DKK 268,222 compared with DKK 38,863 the year before. That is an increase of 38.5% compared with the year before. Equity in the 2019 report amounted to DKK 3,781,236. The solvency ratio was 13.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 6,339,646
- Profit/Loss
- DKK 268,222
- Equity
- DKK 3,781,236
- Total Assets
- DKK 27,124,831
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 6.3 mio. | 268 t. | 3.8 mio. | 1 |
| 2018 | - | 4.6 mio. | 39 t. | 3.5 mio. | 1 |
| 2017 | - | 557 t. | -2.2 mio. | 436 t. | 1 |
| 2016 | - | 1.9 mio. | 27 t. | 167 t. | - |
| 2015 | - | 266 t. | -1 mio. | 140 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Biopsafe ApS has published its interim report for the period April 1, 2018 – December 31, 2018.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.